An emergency doctor has offered some vital advice about your skin, concerned that many people could be putting their health ...
University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also ...
The severity of skin reactions to the treatment of actinic keratosis with 5-fluorouracil cream 4% was associated with a higher lesion clearance rate.
Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic ...
Discover studies that have shown that psoriasis patients exhibit elevated intestinal permeability, correlating with ...
About SciBase SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care ...
Nemluvio has received approval from the European Commission to treat moderate to severe atopic dermatitis and prurigo ...
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...
The following is a summary of “Validity of diagnosis codes to identify a dermatomyositis cohort from electronic health records,” published in the January 2025 issue of Dermatology by Silberzweig et al ...
The medication, also approved in the United States, is the first approved monoclonal antibody that specifically blocks the ...
News Medical on MSN10d
Immunotherapy reduces sunspots and skin cancer by 65%University of Queensland researchers have discovered immunotherapy, when used to treat people with advanced cancers, also helps reduce sunspots and skin cancers by at least 65 per cent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback